BCMNY
AGN

Buckingham Capital Management (New York)’s Allergan plc AGN Stock Holding History

Buckingham Capital Management (New York)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21,132
Closed -$5.14M – 98
2017
Q2 		$5.14M Buy
21,132
+132
+0.6% +$31K 0.6% 68
2017
Q1 		$5.02M Hold
21,000
– – 0.67% 60
2016
Q4 		$4.41M Buy
21,000
+12,511
+147% +$2.59M 0.58% 66
2016
Q3 		$1.96M Sell
8,489
-181
-2% -$44.2K 0.24% 80
2016
Q2 		$2M Buy
+8,670
New +$2M 0.24% 72

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Buckingham Capital Management (New York)'s AGN Position: Q3 2017 in Review

Buckingham Capital Management (New York) sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 21,132 shares — an estimated $5.14M sold.

Buckingham Capital Management (New York) first reported a position in AGN in Q2 2016 and held it in 5 quarters. The position peaked at $5.14M in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Buckingham Capital Management (New York) reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Buckingham Capital Management (New York) sold 21,132 Allergan plc shares in Q3 2017, an estimated $5.14M.
  • Buckingham Capital Management (New York) first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • Buckingham Capital Management (New York)'s Allergan plc position peaked at $5.14M in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Buckingham Capital Management (New York)'s 13F filing for Q3 2017, filed 13 Nov 2017.